Conclusions & Recommendations
15.1.5 - General Recommendations to ITI
Conclusion/Recommendation:
ITI should convey the TEC’s congratulations to Morocco on their successful achievement of validation of elimination
Action:
ITI and Pfizer planned a side event at the World Health Assembly in May to celebrate Morocco’s achievement
TEC 15
2016
Eastern Mediterranean
Morocco
15.1.6 - General Recommendations to ITI
Conclusion/Recommendation:
TEC recommends to ITI to conduct an assessment of how the open data provided through the Zithromax® Tracking System is used, and gather feedback on the System from partners
Action:
This assessment is planned once partners have had more time to use the tool (which went live in March)
TEC 15
2016
supply chain, recommendations for ITI management
15.1.7 - General Recommendations to ITI
Conclusion/Recommendation:
TEC recommends to ITI to communicate to Mali the change in providing Zithromax® at surgery only for countries with ongoing MDA
Action:
Done
TEC 15
2016
Africa - West
Mali
trichiasis, Zithromax® donation criteria
15.1.8 - General Recommendations to ITI
Conclusion/Recommendation:
Dr. Babar Qureshi will be “Deputy Chair” in case TEC Chair is unable to participate in a meeting
Action:
No action required
TEC 15
2016
TEC meeting management
15.1.9 - General Recommendations to ITI
Conclusion/Recommendation:
ITI management will develop a TEC member skills matrix to identify whether there are any skills gaps in the current membership
Action:
Done and will be discussed at TEC closed door lunch during TEC 16
TEC 15
2016
TEC meeting management
15.2.1 - Zithromax® for Refugee Camps
Conclusion/Recommendation:
TEC recommends that ITI work with host governments to assist them in applying for Zithromax® for MDA in refugee camps if prevalence data indicates that treatments are warranted, and there is funding and an implementing partner
Action:
Done
TEC 15
2016
special populations, Zithromax® donation criteria, recommendations for ITI management
15.2.2 - Zithromax® for Refugee Camps
Conclusion/Recommendation:
TEC recommends that ITI discuss with WHO how best to engage UNHCR in the offer to provide Zithromax® to treat trachoma in refugee camps
Action:
No action required
TEC 15
2016
special populations, recommendations for ITI management, Zithromax® donation criteria
15.2.3 - Zithromax® for Refugee Camps
Conclusion/Recommendation:
TEC requests the Refugee and IDP Subcommittee to develop a decision tree for TEC to better understand how to consider requests in different scenarios
Action:
Done and will be presented during TEC 16
TEC 15
2016
Zithromax® donation criteria, special populations
15.3.1 - Zithromax® Donation at Surgery
Conclusion/Recommendation:
TEC recommends that Zithromax® continue to be donated for individual use at trichiasis surgery only in countries with ongoing mass drug administration
Action:
Implemented and countries are being informed as the issue is relevant
TEC 15
2016
trichiasis, Zithromax® donation criteria
15.3.2 - Zithromax® Donation at Surgery
Conclusion/Recommendation:
TEC recommends that the ITI team collect detailed information from countries requesting Zithromax® for use at trichiasis surgery to contribute to the review process. Detailed information includes:
- The ultimate intervention goal for TT surgery,
- The annual intervention objective for TT surgery,
- Confirmation of availability of funds to conduct surgeries,
- Identification of partners conducting surgeries,
- Surgical delivery method, and
- Management of Zithromax® donated for use at TT surgery
Action:
Implemented by program team as part of the annual application process
TEC 15
2016
TEC meeting management, recommendations for ITI management, trichiasis, Zithromax® donation criteria